Clinical Science| Volume 62, ISSUE 3, P411-416, March 2013

Download started.


Influence of daily alcohol consumption on serum adiponectin levels in men

Published:October 02, 2012DOI:



      The risk of cardiovascular diseases is lower among moderate alcohol drinkers than among both nondrinkers and heavy drinkers. However, factors that can account for the U-shaped or J-shaped relationship between daily alcohol consumption and incident cardiovascular diseases remain obscure.


      The present cross-sectional study investigated the relationship between alcohol consumption and serum adiponectin levels.


      Total adiponectin was measured in 527 males participating in health check-up programs (age range 40–86 years, mean 60.5 years). Based on questionnaire responses, alcohol intake was categorized into three groups: none or occasional (A1); <50 g/day and ≥3 days/week (A2); and ≥50 g/day and ≥3 days/week (A3).


      No significant differences in adiponectin levels were observed among the three alcohol consumption groups of subjects without the metabolic syndrome (MetS). In subjects with the MetS, the adiponectin level was significantly higher in the A2 (moderate drinker) group than in both the A1 and A3 groups. MetS subjects in group A2 had higher HDL-C levels than those in A1, but levels in group A3 were not significantly different from those in group A2.


      An increased adiponectin level in moderate alcohol drinkers who have MetS may contribute to the U-shaped relationship between alcohol consumption and risk of cardiovascular events, in addition to the involvement of HDL-C.


      HDL-C (high-density lipoprotein cholesterol), MetS (metabolic syndrome), EDTA (ethylene diamine tetra acetic acid), IRI (immunoreactive insulin), CVs (coefficients of variation), ELISA (enzyme-linked immunosorbent assay), HOMA-IR (homeostasis model assessment of insulin resistance), eGFR (estimated glomerular filtration rate), HbA1c (glycosylated hemoglobin), HPLC (high performance liquid chromatography), JDS (Japan Diabetes Society), NGSP (National Glycohemoglobin Standardization Program), sBP (systolic blood pressure), dBP (diastolic blood pressure), LDL-C (low-density lipoprotein cholesterol), CRP (C-reactive protein)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Iso H.
        • Baba S.
        • Mannami T.
        • Sasaki S.
        • Okada K.
        • Konishi M.
        • et al.
        Alcohol consumption and risk of stroke among middle-age men: the JPHC Study Cohort I..
        Stroke. 2004; 35: 1124-1129
        • Reynolds K.
        • Lewis B.
        • Nolen J.D.
        • Kinney G.L.
        • Sathya B.
        • He J.
        Alcohol consumption and risk of stroke: a meta-analysis.
        JAMA. 2003; 289: 579-588
        • Berger K.
        • Ajani U.A.
        • Kase C.S.
        • Gaziano J.M.
        • Buring J.E.
        • Glynn R.J.
        • et al.
        Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians.
        N Engl J Med. 1999; 341: 1557-1564
        • Yano K.
        • Rhoads G.G.
        • Kagan A.
        Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii.
        N Engl J Med. 1977; 297: 405-409
        • Langer R.D.
        • Criqui M.H.
        • Reed D.M.
        Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease.
        Circulation. 1992; 85: 910-915
        • Shaper A.G.
        • Wannamethee G.
        • Walker M.
        Alcohol and coronary heart disease: a perspective from the British Regional Heart Study.
        Int J Epidemiol. 1994; 23: 482-494
        • Gordon T.
        • Kannel W.B.
        Drinking habits and cardiovascular disease: the Framingham Study.
        Am Heart J. 1985; 110: 331-334
        • Miller G.J.
        • Beckles G.L.
        • Maude G.H.
        • Carson D.C.
        Alcohol consumption: protection against coronary heart disease and risks to health.
        Int J Epidemiol. 1990; 19: 923-930
        • Kitamura A.
        • Iso H.
        • Sankai T.
        • Naito Y.
        • Sato S.
        • Kiyama M.
        • et al.
        Alcohol intake and premature coronary heart disease in urban Japanese men.
        Am J Epidemiol. 1998; 147: 59-65
        • Emberson J.R.
        • Shaper A.G.
        • Wannamethee S.G.
        • Morris R.W.
        • Whincup P.H.
        Alcohol intake in middle age and risk of cardiovascular disease and mortality: accounting for intake variation over time.
        Am J Epidemiol. 2005; 161: 856-863
        • Ronksley P.E.
        • Brien S.E.
        • Turner B.J.
        • Mukamal K.J.
        • Ghali W.A.
        Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis.
        BMJ. 2011; 342: d671
        • Howard A.A.
        • Arnsten J.H.
        • Gourevitch M.N.
        Effect of alcohol consumption on diabetes mellitus: a systematic review.
        Ann Intern Med. 2004; 140: 211-219
        • Sierksma A.
        • Patel H.
        • Ouchi N.
        • Kihara S.
        • Funahashi T.
        • Heine R.J.
        • et al.
        Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity.
        Diabetes Care. 2004; 27: 184-189
        • Imhof A.
        • Plamper I.
        • Maier S.
        • Trischler G.
        • Koenig W.
        Effect of drinking on adiponectin in healthy men and women: a randomized intervention study of water, ethanol, red wine, and beer with or without alcohol.
        Diabetes Care. 2009; 32: 1101-1103
        • Brien S.E.
        • Ronksley P.E.
        • Turner B.J.
        • Mukamal K.J.
        • Ghali W.A.
        Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies.
        BMJ. 2011; 342: d636
        • Makita S.
        • Onoda T.
        • Ohsawa M.
        • Tanaka F.
        • Segawa T.
        • Takahash T.
        • et al.
        Influence of mild-to-moderate alcohol consumption on cardiovascular diseases in men from the general population.
        Atherosclerosis. 2012; 224: 222-227
        • Makita S.
        • Abiko A.
        • Naganuma Y.
        • Moriai Y.
        • Nakamura M.
        Effects of telmisartan on adiponectin levels and body weight in hypertensive patients with glucose intolerance.
        Metabolism. 2008; 57: 1473-1478
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • Naylor B.A.
        • Treacher D.F.
        • Turner R.C.
        Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Matsuo S.
        • Imai E.
        • Horio M.
        • Yasuda Y.
        • Tomita K.
        • Nitta K.
        • et al.
        Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan..
        Am J Kidney Dis. 2009; 53: 982-992
        • Task Force for Japanese Metabolic Syndrome Criteria
        Metabolic syndrome: definition and diagnostic criteria in Japan.
        J Jpn Soc Intern Med. 2005; 94 (in Japanese): 794-809
        • Rimm E.B.
        • Williams P.
        • Fosher K.
        • Criqui M.
        • Stampfer M.J.
        Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors.
        BMJ. 1999; 319: 1523-1528
        • Kiechl S.
        • Willeit J.
        • Poewe W.
        • Egger G.
        • Oberhollenzer F.
        • Muggeo M.
        • et al.
        Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study).
        BMJ. 1996; 313: 1040-1044
        • Imhof A.
        • Woodward M.
        • Doering A.
        • Helbecque N.
        • Loewel H.
        • Amouyel P.
        • et al.
        Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille).
        Eur Heart J. 2004; 25: 2092-2100
        • Sierksma A.
        • van der Gaag M.S.
        • Kluft C.
        • Hendriks H.F.
        Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study.
        Eur J Clin Nutr. 2002; 56: 1130-1136
        • Beulens J.W.
        • de Zoete E.C.
        • Kok F.J.
        • Schaafsma G.
        • Hendriks H.F.
        Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study.
        Eur J Clin Nutr. 2008; 62: 1098-1105
        • Beulens J.W.
        • van Beers R.M.
        • Stolk R.P.
        • Schaafsma G.
        • Hendriks H.F.
        The effect of moderate alcohol consumption on fat distribution and adipocytokines.
        Obesity (Silver Spring). 2006; 14: 60-66
        • Pischon T.
        • Girman C.J.
        • Rifai N.
        • Hotamisligil G.S.
        • Rimm E.B.
        Association between dietary factors and plasma adiponectin concentrations in men.
        Am J Clin Nutr. 2005; 81: 780-786
        • Gigleux I.
        • Gagnon J.
        • St-Pierre A.
        • Cantin B.
        • Dagenais G.R.
        • Meyer F.
        • et al.
        Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome.
        J Nutr. 2006; 136: 3027-3032
        • Suh I.
        • Shaten B.J.
        • Cutler J.A.
        • Kuller L.H.
        Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group.
        Ann Intern Med. 1992; 116: 881-887